CYTK

Cytokinetics, Incorporated News Headlines

$5.87
*  
0.35
6.34%
Get CYTK Alerts
*Delayed - data as of Dec. 24, 2014  -  Find a broker to begin trading CYTK now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
LIFE Explores China's Growth Potential - Analyst Blog
3/28/2013 2:28:46 PM - Zacks.com


Affymetrix Inks Deal with UK Biobank - Analyst Blog
3/28/2013 1:29:24 PM - Zacks.com


Takeda Files Adcetris in Japan - Analyst Blog
3/27/2013 2:26:29 PM - Zacks.com


Acorda Reports Data on Epilepsy Drug - Analyst Blog
3/26/2013 3:27:57 PM - Zacks.com


Integra's Second Cobalt Chrome Rod - Analyst Blog
3/26/2013 3:25:44 PM - Zacks.com


Zimmer Optimistic About New Product - Analyst Blog
3/26/2013 3:17:01 PM - Zacks.com


CHMP Negative on Gentium Candidate - Analyst Blog
3/26/2013 9:28:43 AM - Zacks.com


CHMP Positive on Ariad's Iclusig - Analyst Blog
3/25/2013 5:27:49 PM - Zacks.com


CHMP Still Negative on Isis' Kynamro - Analyst Blog
3/25/2013 4:32:02 PM - Zacks.com


Pipeline Setback at BioLineRx - Analyst Blog
3/25/2013 3:29:40 PM - Zacks.com


CHMP Positive on Biogen's Tecfidera - Analyst Blog
3/25/2013 9:29:17 AM - Zacks.com


Cytokinetics: Critical Phase IIb Data Is Upcoming In 2013 For Omecamtiv Mecarbil And Tirasemtiv
3/25/2013 8:56:11 AM - SeekingAlpha


FDA Nod for Integra's Extremity Offer - Analyst Blog
3/22/2013 5:29:06 PM - Zacks.com


NICE News for InterMune - Analyst Blog
3/22/2013 5:26:11 PM - Zacks.com


PetMed Reiterated at Outperform - Analyst Blog
3/22/2013 4:27:20 PM - Zacks.com


Zimmer Expands Knee Product Offering - Analyst Blog
3/22/2013 3:25:40 PM - Zacks.com


More Protection for Biogen's Tecfidera - Analyst Blog
3/22/2013 9:25:02 AM - Zacks.com


Data on BioMarin's BMN-701 - Analyst Blog
3/21/2013 5:26:38 PM - Zacks.com


Good News for Nymox's Pipeline - Analyst Blog
3/21/2013 5:23:03 PM - Zacks.com


ISIS Presents Promising Data - Analyst Blog
3/21/2013 3:29:03 PM - Zacks.com


SGEN Seeks Adcetris Label Expansion - Analyst Blog
3/19/2013 6:15:01 PM - Zacks.com


DGX to Launch Dementia Test Panel - Analyst Blog
3/19/2013 5:44:59 PM - Zacks.com


Affymax to Cut 75% of Workforce - Analyst Blog
3/19/2013 4:45:01 PM - Zacks.com


New Data on Biogen/Elan's Tysabri - Analyst Blog
3/19/2013 3:44:21 PM - Zacks.com


SPPI Acquires Late-Stage Candidate - Analyst Blog
3/18/2013 5:45:44 PM - Zacks.com